Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Martí Farrera"'
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/f5f2fe4dc048440c9e96941a56d8d0ef
Autor:
Ayk Waldow, Laura-Sophie Beier, Janine Arndt, Simon Schallenberg, Claudia Vollbrecht, Philip Bischoff, Martí Farrera-Sal, Florian N. Loch, Christian Bojarski, Michael Schumann, Lars Winkler, Carsten Kamphues, Lukas Ehlen, Jörg Piontek
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1980 (2023)
Claudins regulate paracellular permeability, contribute to epithelial polarization and are dysregulated during inflammation and carcinogenesis. Variants of the claudin-binding domain of Clostridium perfringens enterotoxin (cCPE) are highly sensitive
Externí odkaz:
https://doaj.org/article/dd7af9b4ff8a4d9d825bc64bed3e2388
Autor:
Martí Farrera-Sal, Rafael Moreno, Ana Mato-Berciano, María Victoria Maliandi, Miriam Bazan-Peregrino, Ramon Alemany
Publikováno v:
Molecular Therapy: Oncolytics, Vol 22, Iss , Pp 27-35 (2021)
Oncolytic viruses (OVs) preferentially infect and selectively replicate in cancer cells. OVs have been tested in clinical trials as monotherapy or in combination with chemotherapy, radiotherapy, and immunotherapy. However, the dense extracellular mat
Externí odkaz:
https://doaj.org/article/53162dbaea10419f849febb02f78afae
Autor:
Gabriel Capellá, Francisco X Real, Marta Gil-Martin, Rocio Garcia-Carbonero, Rafael Moreno, Ramon Alemany, Martí Farrera-Sal, Ramon Salazar, Teresa Macarulla, Jaime Martinez de Villarreal, Natalia del Pozo, Carmen Guillén-Ponce, Miriam Bazan-Peregrino, Rafael Álvarez, Ana Mato-Berciano, Emma Blasi, Carmen Blasco, Manel Cascallo, Maria C Riesco-Martinez, Helena Verdaguer, Maria Victoria Maliandi, Silvia Torres-Manjon, Marcel Costa, Noemí Vidal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background VCN-01 is an oncolytic adenovirus (Ad5 based) designed to replicate in cancer cells with dysfunctional RB1 pathway, express hyaluronidase to enhance virus intratumoral spread and facilitate chemotherapy and immune cells extravasation into
Externí odkaz:
https://doaj.org/article/f20744c4524742ac8290f86ad68345d4
Autor:
Jana de Sostoa, Carlos Alberto Fajardo, Rafael Moreno, Maria D. Ramos, Martí Farrera-Sal, Ramon Alemany
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-15 (2019)
Abstract Background Oncolytic virus (OV)-based therapies have an emerging role in the treatment of solid tumors, involving both direct cell lysis and immunogenic cell death. Nonetheless, tumor-associated stroma limits the efficacy of oncolytic viruse
Externí odkaz:
https://doaj.org/article/54699afec5424ff2960cbfd6795cac48
Autor:
Ahmed Abdullah Al-Zaher, Rafael Moreno, Carlos Alberto Fajardo, Marcel Arias-Badia, Martí Farrera, Jana de Sostoa, Luis Alfonso Rojas, Ramon Alemany
Publikováno v:
Molecular Therapy: Oncolytics, Vol 8, Iss , Pp 62-70 (2018)
To enhance adenovirus-mediated oncolysis, different approaches that tackle the selectivity, tumor penetration, and spreading potential of oncolytic adenoviruses have been reported. We have previously demonstrated that insertion of the internalizing A
Externí odkaz:
https://doaj.org/article/0a2e8c7b9ae940cbaf08ac217ac2324d
Autor:
Rocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín, Rafael Álvarez, Teresa Macarulla, Maria C Riesco-Martinez, Helena Verdaguer, Carmen Guillén-Ponce, Martí Farrera-Sal, Rafael Moreno, Ana Mato-Berciano, Maria Victoria Maliandi, Silvia Torres-Manjon, Marcel Costa, Natalia del Pozo, Jaime Martínez de Villarreal, Francisco X Real, Noemí Vidal, Gabriel Capella, Ramon Alemany, Emma Blasi, Carmen Blasco, Manel Cascalló, Ramon Salazar
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
Universidad de Barcelona
Scientia
BackgroundVCN-01 is an oncolytic adenovirus (Ad5 based) designed to replicate in cancer cells with dysfunctional RB1 pathway, express hyaluronidase to enhance virus intratumoral spread and facilitate chemotherapy and immune cells extravasation into t
Autor:
Miriam Bazan-Peregrino, Ramon Alemany, Maria Victoria Maliandi, Rafael Moreno, Ana Mato-Berciano, Martí Farrera-Sal
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Molecular Therapy: Oncolytics, Vol 22, Iss, Pp 27-35 (2021)
Molecular Therapy Oncolytics
Universidad de Barcelona
Molecular Therapy: Oncolytics, Vol 22, Iss, Pp 27-35 (2021)
Molecular Therapy Oncolytics
Oncolytic viruses (OVs) preferentially infect and selectively replicate in cancer cells. OVs have been tested in clinical trials as monotherapy or in combination with chemotherapy, radiotherapy, and immunotherapy. However, the dense extracellular mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60b95bc7488e4c0d1b515d545d3731e8
http://hdl.handle.net/2445/180605
http://hdl.handle.net/2445/180605
Autor:
Giancarlo Castellano, David Medel, Marc Otero-Mateo, Martí Farrera-Sal, Eneko Villanueva, Cristina Fillat, Ramon Alemany, Rafael Moreno, Estela Núñez-Manchón
Publikováno v:
NAR Cancer
Arming oncolytic adenoviruses with therapeutic transgenes is a well-established strategy for multimodal tumour attack. However, this strategy sometimes leads to unexpected attenuated viral replication and a loss of oncolytic effects, preventing these
Autor:
Marcel Arias-Badia, Mireia M. Ginestà, Silvia Torres-Manjon, Sara Morgado, Martí Farrera-Sal, Ana Mato-Berciano, Marta Gimenez-Alejandre, Maria Victoria Maliandi, Luis A. Rojas, Paz Moreno, Manel Cascallo, Miriam Bazan-Peregrino, Ramon Alemany, Rafael Moreno, Gabriel Capellá
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 332
Tumor targeting and intratumoral virus spreading are key features for successful oncolytic virotherapy. VCN-11 is a novel oncolytic adenovirus, genetically modified to express hyaluronidase (PH20) and display an albumin-binding domain (ABD) on the he